{"database": "lobbying", "table": "lobbying_activities", "rows": [[2467142, "852a4369-0347-47cc-bc7d-56ad78f140e1", "Q2", "MEHLMAN CONSULTING, INC.", 284950, "AARP, INC.", 2020, "second_quarter", "PHA", "S.1895 - Lower Health Care Costs Act including issues relating to drug pricing \nOlder Americans Reauthorization Act\nS. 2543 - Prescription Drug Pricing Reduction Act of 2019.\nHouse prescription drug price transparency legislation.", "HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of", 50000, null, 0, 0, "2020-07-15T18:54:36.670000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2467142"], "units": {}, "query_ms": 21.101030986756086, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}